JP2013544838A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544838A5 JP2013544838A5 JP2013542043A JP2013542043A JP2013544838A5 JP 2013544838 A5 JP2013544838 A5 JP 2013544838A5 JP 2013542043 A JP2013542043 A JP 2013542043A JP 2013542043 A JP2013542043 A JP 2013542043A JP 2013544838 A5 JP2013544838 A5 JP 2013544838A5
- Authority
- JP
- Japan
- Prior art keywords
- retinal
- medicament
- retinal pigment
- medicament according
- acute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 10
- 208000017442 Retinal disease Diseases 0.000 claims 4
- 230000001154 acute effect Effects 0.000 claims 4
- 208000034247 Pattern dystrophy Diseases 0.000 claims 2
- 208000034461 Progressive cone dystrophy Diseases 0.000 claims 2
- 206010038821 Retinal anomaly congenital Diseases 0.000 claims 2
- 201000007737 Retinal degeneration Diseases 0.000 claims 2
- 208000000208 Wet Macular Degeneration Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 201000008615 cone dystrophy Diseases 0.000 claims 2
- 208000011325 dry age related macular degeneration Diseases 0.000 claims 2
- 239000000790 retinal pigment Substances 0.000 claims 2
- 210000003583 retinal pigment epithelium Anatomy 0.000 claims 2
- 208000001344 Macular Edema Diseases 0.000 claims 1
- 206010025415 Macular oedema Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010038848 Retinal detachment Diseases 0.000 claims 1
- 208000016624 Retinal neoplasm Diseases 0.000 claims 1
- 208000032398 Retinal pigment epitheliopathy Diseases 0.000 claims 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 201000010230 macular retinal edema Diseases 0.000 claims 1
- 230000036542 oxidative stress Effects 0.000 claims 1
- 208000024725 retina neoplasm Diseases 0.000 claims 1
- 201000008933 retinal cancer Diseases 0.000 claims 1
- 230000004264 retinal detachment Effects 0.000 claims 1
- 230000002207 retinal effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41966010P | 2010-12-03 | 2010-12-03 | |
| US61/419,660 | 2010-12-03 | ||
| PCT/US2011/061370 WO2012074788A1 (en) | 2010-12-03 | 2011-11-18 | Methods for treating diseases of the retina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013544838A JP2013544838A (ja) | 2013-12-19 |
| JP2013544838A5 true JP2013544838A5 (https=) | 2015-01-15 |
Family
ID=45507856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013542043A Pending JP2013544838A (ja) | 2010-12-03 | 2011-11-18 | 網膜の疾患を治療するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9018202B2 (https=) |
| EP (1) | EP2646034A1 (https=) |
| JP (1) | JP2013544838A (https=) |
| KR (1) | KR20130122958A (https=) |
| CN (1) | CN103327981A (https=) |
| AU (1) | AU2011336976A1 (https=) |
| BR (1) | BR112013013636A2 (https=) |
| CA (1) | CA2819616A1 (https=) |
| RU (1) | RU2013129748A (https=) |
| WO (1) | WO2012074788A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10752593B2 (en) | 2018-12-28 | 2020-08-25 | Endogena Therapeutics, Inc. | Compounds for use as therapeutically active substances in the treatment of retinal diseases |
| JP6864327B2 (ja) | 2017-07-06 | 2021-04-28 | 山田 健一 | 脂質過酸化誘発性疾患の治療薬およびそのスクリーニング方法 |
| US10807973B2 (en) | 2018-12-28 | 2020-10-20 | Endogena Therapeutics, Inc. | Compounds for use as therapeutically active substances in the treatment of retinal diseases |
| EP3919052A4 (en) * | 2019-01-09 | 2022-10-05 | Fuso Pharmaceutical Industries, Ltd. | Pharmaceutical composition for intraocular or oral administration for treatment of retinal diseases |
| US20250170143A1 (en) * | 2022-04-14 | 2025-05-29 | Mayo Foundation For Medical Education And Research | Methods of treating ocular fibrotic pathologies |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1004520A1 (en) | 1992-05-13 | 1998-11-27 | Novartis Ag | Ophthalmic compositions containing a cyclosporin |
| US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| US5631250A (en) | 1995-03-24 | 1997-05-20 | Eli Lilly And Company | Process and solvate of 2-methyl-thieno-benzodiazepine |
| US5744468A (en) * | 1996-10-23 | 1998-04-28 | Tong-Ho Lin | Hypotensive intraocular pressure activity of clozapine and sulpiride |
| JPH10175865A (ja) * | 1996-12-11 | 1998-06-30 | Towa Rin | 抗眼圧活性製剤 |
| US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
| JP2002530340A (ja) * | 1998-11-23 | 2002-09-17 | セプラコール， インク． | オランザピン−ｎ−オキサイドを含む医薬組成物 |
| DE10206941A1 (de) | 2002-02-19 | 2003-09-25 | Goetz Nowak | Neue Arzneimittel |
| JP2006515628A (ja) * | 2003-01-23 | 2006-06-01 | アカディア ファーマシューティカルズ，インコーポレーテッド | ヒト神経精神疾患を処置するためのｎ−デスメチルクロザピンの使用 |
| WO2004103263A2 (en) | 2003-05-22 | 2004-12-02 | Yeda Research And Development Co. Ltd. | Dopamine and agonists and antagonists thereof for treatment of neurodegenerative diseases |
| US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| US20050277584A1 (en) | 2004-06-09 | 2005-12-15 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
| US20060035887A1 (en) | 2004-07-02 | 2006-02-16 | Dr. Reddy's Laboratories Limited | Process for preparing olanzapine |
| AU2005271513A1 (en) * | 2004-08-05 | 2006-02-16 | Acadia Pharmaceuticals Inc. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| CN101437478A (zh) * | 2004-10-04 | 2009-05-20 | Qlt美国有限公司 | 聚合送递制剂的眼部送递 |
| MX2007003789A (es) | 2004-10-04 | 2007-07-20 | Qlt Usa Inc | Suministro ocular de formulaciones polimericas para suministro. |
| US7297679B2 (en) | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
| US20070015691A1 (en) | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
| WO2008111497A1 (ja) * | 2007-03-08 | 2008-09-18 | Santen Pharmaceutical Co., Ltd. | トリテルペノイドを有効成分として含有する酸化ストレスが関連する眼疾患の予防又は治療剤 |
| CN101711236B (zh) * | 2007-04-12 | 2012-10-31 | Nsab神经研究瑞典公司分公司 | 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物 |
-
2011
- 2011-11-16 US US13/298,028 patent/US9018202B2/en active Active
- 2011-11-18 WO PCT/US2011/061370 patent/WO2012074788A1/en not_active Ceased
- 2011-11-18 CA CA 2819616 patent/CA2819616A1/en not_active Abandoned
- 2011-11-18 JP JP2013542043A patent/JP2013544838A/ja active Pending
- 2011-11-18 KR KR20137017036A patent/KR20130122958A/ko not_active Ceased
- 2011-11-18 BR BR112013013636A patent/BR112013013636A2/pt not_active IP Right Cessation
- 2011-11-18 EP EP11810917.2A patent/EP2646034A1/en not_active Withdrawn
- 2011-11-18 RU RU2013129748/15A patent/RU2013129748A/ru not_active Application Discontinuation
- 2011-11-18 CN CN2011800652550A patent/CN103327981A/zh active Pending
- 2011-11-18 AU AU2011336976A patent/AU2011336976A1/en not_active Abandoned
-
2015
- 2015-04-27 US US14/696,789 patent/US9561234B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544838A5 (https=) | ||
| BR112014003225A2 (pt) | profármacos de treprostinil ligados a veículo | |
| WO2012122340A8 (en) | Soluble guanylate cyclase activators | |
| JP2015535257A5 (https=) | ||
| JP2014515038A5 (https=) | ||
| JP2013522367A5 (https=) | ||
| WO2016065226A8 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| JP2016503793A5 (https=) | ||
| WO2010048332A3 (en) | Compounds for treating ophthalmic diseases and disorders | |
| SG10201407013QA (en) | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | |
| JP2017500289A5 (https=) | ||
| JP2015523546A5 (https=) | ||
| JP2016510326A5 (https=) | ||
| HK1219943A1 (zh) | 用於治疗眼科疾病和障害的取代3-苯基丙胺衍生物 | |
| JP2016511753A5 (https=) | ||
| JP2014511374A5 (https=) | ||
| HK1244806A1 (zh) | 作為過氧乙醯硝酸整聯蛋白拮抗劑的間氮雜環氨基苯甲酸衍生物 | |
| JP2012530758A5 (https=) | ||
| JP2013523846A5 (https=) | ||
| JP2016531126A5 (https=) | ||
| WO2010028088A3 (en) | Sulfur-linked compounds for treating opthalmic diseases and disorders | |
| WO2014145686A3 (en) | Novel cyclosporin derivatives and uses thereof | |
| WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| JP2014506582A5 (https=) |